American Journal of Epidemiology Vol. 124, No. 4: 624-632
Copyright © 1986 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
IS THE LEVEL OF SERUM TRIGLYCERIDE A SIGNIFICANT PREDICTOR OF CORONARY DEATH IN "NORMOCHOLESTEROLEMIC" SUBJECTS?
THE PARIS PROSPECTIVE STUDY
1 INSERM U258 Epidémiologie cardiovasculaire, Paris, France
2Laboratoire de Recherche de la Direction de l'Action Sanitaire et Sociale Paris, France
Reprint requests to Dr. Francois Cambien, INSERM U258, Hopital Broussais, 96 Rue Didot, 75674 Paris CEDEX 14, France
Since the relation between serum triglyceride level and coronary heart disease after adjustment for cholesterol and other risk factors remains controversial, the authors have tested the hypothesis that it could be different according to the level of serum cholesterol, i.e., that there may be an interaction between cholesterol and triglyceride level in prediction of coronary heart disease risk. The data of the Paris Prospective Study were used to carry out a survival analysis, by using the Cox model, with coronary heart disease death as the end point and triglyceride and different risk factors as the predictor variables. In this study, during a mean follow-up of 11.4 ± 2.2 years, 157 coronary heart disease deaths occurred. Serum triglyceride level is not an independent predictor of coronary heart disease death after adjustment for serum cholesterol. However, when cholesterol, triglyceride, and their interaction term are introduced in the regression equation, all variables contribute significantly to the risk. This is also true when other risk factors are taken into account. As a consequence of this interaction, among the 3,585 subjects with a serum cholesterol level lower than 220 mg/100 ml, serum triglyceride level is an independent predictor of risk, even after adjustment for all other risk factors.
cholesterol; death; heart diseases; triglycerides
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. H. Criqui Triglycerides and Coronary Heart Disease Revisited (Again) Ann Intern Med, September 18, 2007; 147(6): 425 - 427. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sarwar, J. Danesh, G. Eiriksdottir, G. Sigurdsson, N. Wareham, S. Bingham, S. M. Boekholdt, K.-T. Khaw, and V. Gudnason Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies Circulation, January 30, 2007; 115(4): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Okada, T. Saito, H. Yoshimura, Y. Noguchi, T. Ito, H. Sasaki, and H. Hama Surfactant-Based Homogeneous Assay for the Measurement of Triglyceride Concentrations in VLDL and Intermediate-Density Lipoprotein Clin. Chem., October 1, 2005; 51(10): 1804 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Asia Pacific Cohort Studies Collaboration Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region Circulation, October 26, 2004; 110(17): 2678 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mittendorfer, B. W. Patterson, S. Klein, and L. S. Sidossis VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E708 - E715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mittendorfer, B. W Patterson, and S. Klein Effect of sex and obesity on basal VLDL-triacylglycerol kinetics Am. J. Clinical Nutrition, March 1, 2003; 77(3): 573 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mittendorfer, B. W. Patterson, and S. Klein Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E549 - E556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Iso, Y. Naito, S. Sato, A. Kitamura, T. Okamura, T. Sankai, T. Shimamoto, M. Iida, and Y. Komachi Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women Am. J. Epidemiol., March 1, 2001; 153(5): 490 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Avins and J. M. Neuhaus Do Triglycerides Provide Meaningful Information About Heart Disease Risk? Arch Intern Med, July 10, 2000; 160(13): 1937 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Oberman Hypertriglyceridemia and Coronary Heart Disease J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2098 - 2105. [Full Text]
|
|
|
|
|
|
E. T. Leary, T. Wang, D. J. Baker, D. D. Cilla, J. Zhong, G. R. Warnick, K. Nakajima, and R. J. Havel Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma Clin. Chem., December 1, 1998; 44(12): 2490 - 2498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. McNamara, P. K. Shah, K. Nakajima, L. A. Cupples, P. W. F. Wilson, J. M. Ordovas, and E. J. Schaefer Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study Clin. Chem., June 1, 1998; 44(6): 1224 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hayashi, M. Gohda, S. Matzno, Y. Kubo, H. Kido, T. Yamauchi, and N. Nakamura Possible Mechanism of Action of AE0047, a Calcium Antagonist, on Triglyceride Metabolism J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 882 - 890. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Alaupovic, W. J. Mack, C. Knight-Gibson, and H. N. Hodis The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial Arterioscler Thromb Vasc Biol, April 1, 1997; 17(4): 715 - 722. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Napoli, S. Lepore, P. Chiariello, M. Condorelli, and M. Chiariello Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(1): 17 - 26. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Prisco, S. Caciolli, S. Del Pace, and G. F. Gensini State-of-the-Art Review : Sex and Cardiovascular Risk Factors Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 94 - 102. [PDF]
|
|
|
|
|
|
C. M. Burchfiel, A. Laws, R. Benfante, R. J. Goldberg, L.-J. Hwang, D. Chiu, B. L. Rodriguez, J. D. Curb, and D. S. Sharp Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease Circulation, September 15, 1995; 92(6): 1430 - 1436. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. H. Criqui, G. Heiss, R. Cohn, L. D. Cowan, C. M. Suchindran, S. Bangdiwala, S. Kritchevsky, D. R. Jacobs, H. K. O'Grady, and C.E. Davis Plasma Triglyceride Level and Mortality from Coronary Heart Disease N. Engl. J. Med., April 29, 1993; 328(17): 1220 - 1225. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Grundy and G. L. Vega Two Different Views of the Relationship of Hypertriglyceridemia to Coronary Heart Disease: Implications for Treatment Arch Intern Med, January 1, 1992; 152(1): 28 - 34. [Abstract] [PDF]
|
|